[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575232":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":51,"collaborators":24,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":24,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":24,"enrollmentInfo":61,"targetDuration":24,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":24,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"ResMed","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Investigational algorithm","EXPERIMENTAL","The participants will trial the investigational algorithm and the control algorithm in a randomized order. Each will be used for up to 4 weeks in the home environment in place of their own device\u002Ftherapy. The study device will be set up to align with the majority of the participants current therapy settings.",[13],"Device: Investigational algorithm",{"label":15,"type":16,"description":11,"interventionNames":17},"Control algorithm","ACTIVE_COMPARATOR",[18],"Device: Control algorithm",[20,25],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","Investigational algorithm developed for the treatment of Obstructive Sleep Apnea.",[9],null,{"type":21,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"Released algorithm intended for the treament of Obstructive Sleep Apnea",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Sumudu Herath","CONTACT","+61 288841722","sumudu.herath@resmed.com.au",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"ResMed Ltd","RECRUITING","Bella Vista","New South Wales","2153","Australia","AU",{"type":44,"coordinates":45},"Point",[46,47],150.95456,-33.74127,{"lat":47,"lon":46},[50],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},{"type":52,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100575232","evaluation-of-a-novel-auto-adjusting-positive-airway-pressure-algorithm-for-the-treatment-of-obstructive-sleep-apnea-clinical-study-100575232",false,"NCT06769607","Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study","Inclusion Criteria:\n\n* Participants willing to give written informed consent.\n* Participants who can read and comprehend English.\n* Participants who ≥ 18 years of age\n* Participants who have been using a ResMed AirSense 10 or 11 device.\n* Participants currently using AutoSet (APAP) mode.\n* Participants being established on PAP therapy for the treatment of OSA for approximately \\>3 months.\n* Participants who can participate in the study for up to 8 weeks.\n\nExclusion Criteria:\n\n* Participants using Bilevel flow generators.\n* Participants using CPAP, AutoSet for Her\n* Participants who are or may be pregnant.\n* Participants with a preexisting lung disease\u002F condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\\\u003C 2years) case of pneumonia or lung infection; lung injury.\n* Participants believed to be unsuitable for inclusion by the researcher.\n* Participants who are currently enrolled in other medical clinical studies","ALL","18 Years",{"count":62,"type":63},80,"ESTIMATED","INTERVENTIONAL",[66],"NA","This study aims to assess the effectiveness of an investigational algorithm in the treatment of obstructive sleep apnea.",[69],"Obstructive Sleep Apnea","2025-11-24",{"date":72,"type":73},"2025-12-02","ACTUAL",{"date":75,"type":73},"2025-04-10",{"date":77,"type":63},"2025-12",{"name":5,"class":6},1]